NEW BRUNSWICK, N.J., April 02, 2025--Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback